The effect of walking on fatigue in leukemia patients
Not Applicable
- Conditions
- Acute myeloblastic leukemia.Refractory anaemia with excess blasts in transformation
- Registration Number
- IRCT2017041932788N2
- Lead Sponsor
- Vice chancellor for research of Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
( adult patients with acute leukemia who are aware of their disease; Acute leukemia patients who have received at least two chemotherapy sessions; Age range (60-18) years; Patient do not have history of heart disease, diabetes mellitus, hypertension; before walking have normal vital signs Exclusion criteria: patient's inability to participate in two sessions walking; any unusual changes in vital signs, including pulse, blood pressure and breathing during walking; patient died; Not wanting to continue working)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue. Timepoint: Before the intervention, the end of fifth day of , the end of the tenth day after the intervention. Method of measurement: brief fatigue inventory questionnaire.
- Secondary Outcome Measures
Name Time Method